Moderna (MRNA) reported a bigger-than-expected quarterly loss on Friday, hit by a charge related to its efforts to scale down manufacturing amid weakening demand for its COVID-19 vaccine. The company’s shares were down about 4% in pre-market trading.
Leave A Comment